Form 4: Zivo Bioscience Director Maggiore Reports Stock Transactions
SEC Form 4
Christopher D. Maggiore, a director and 10% owner of Zivo Bioscience, Inc., reported the acquisition and disposal of common stock.
Summary
- On June 11, 2024, Christopher D. Maggiore disposed of 6,273 shares of Zivo Bioscience common stock.
- On June 12, 2024, Maggiore acquired 3,764 shares of common stock at a price of $7.97 per share.
- Following these transactions, Maggiore directly owns 465,027 shares of Zivo Bioscience common stock.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing reporting stock transactions, so the sentiment is neutral.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC for insiders of publicly traded companies, providing transparency into their trading activities. It is difficult to assess the context of the transactions without additional information.
Stakeholder Impact
- The transactions may have a minor impact on shareholder sentiment, depending on how the market interprets the insider's buying and selling activity.
Key Dates
| Date | Description |
|---|---|
| 06/11/2024 | Maggiore disposed of 6,273 shares of common stock. |
| 06/12/2024 | Maggiore acquired 3,764 shares of common stock at $7.97 per share. |
| 06/13/2024 | Date of signature for the Form 4 filing. |
Keywords
Zivo Bioscience, Maggiore, stock transactions, Form 4, beneficial ownership, director, common stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.